ClinicalTrials.gg
CompletedNCT02527070MRT01Updated Oct 17, 2016

Evaluating the State of Microvessels by Minimum Rise Time (MRT01)

An interventional study of RESPeRATE (Paced Breathing) and Quantum Warp10 (Red LED) in Healthy, sponsored by Afeka, The Tel-Aviv Academic College of Engineering. Completed at 1 site in Israel. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-17.

Sponsored by Afeka, The Tel-Aviv Academic College of Engineering · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Photoplethysmography (PPG) is a simple uncalibrated optical method of monitoring variations in skin blood volume. The objective of the current study is to investigate a potential relationship between MRT (minimum rise time, in time units) a measure derived from PPG and the state of microvessels.

This study includes a 1-2 hour single session per subject during which PPG and other microvascular and systemic variables will be monitored in response to non-invasive interventions that are known to elicit microvascular responses.

Read the detailed description

Photoplethysmography (PPG) is a simple uncalibrated optical method of monitoring variations in skin blood volume. A major limitation of PPG is the lack of a quantitative method for calibrating this signal. A method that provides an absolute measure (in time units) called 'minimum rise time' (MRT) was published in 1985 by Dr. Benjamin Gavish, one of the study investigators. However, a possible relationship between MRT and the state of arterioles that determines the microvascular flow has never been investigated. Such relationship, if validated, could have clinical impact in noninvasive diagnosis of vascular diseases and monitoring microvascular response to treatments that affect at both clinic and home setting.

The objective of the current study is to investigate a potential relationship between variations of MRT (minimum rise time, in time units) and microcirculatory variables induced by interventions that are expected to have acute effect on the state of arterioles and the tissue oxygenation.

This study includes a single 1-2 hour session per subject, during which PPG and other microvascular and systemic variables will be monitored in healthy volunteers in response to a number of non-invasive interventions/device that are approved for clinical use and known to elicit microvascular responses. These interventions are applied consecutively, include breathing at different rates, low power visible light in the red-to-near-infrared range, and local temperature changes. The experimental sessions will be conducted at the Afeka College by the study investigators.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Afeka, The Tel-Aviv Academic College of Engineering is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy males and females, between 18 and 65 years of age.
  2. Willing to sign informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Currently smoking
  2. Any abnormal skin condition in the area of light irradiation.
  3. Pregnant having given birth less than 3 months ago, and/or breastfeeding.
  4. Having a history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treated area, unless treatment is conducted following a prophylactic regimen.
  5. Having any illness that might affect the vasculature, such as diabetes (type I or II)
  6. Suffering from significant concurrent illness, such as cardiac disorders, , or pertinent neurological disorders.
  7. As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Red LED

    Light emitting diodes, 670 nm, 50 mW/cm2, Quantum Warp10 (Quantum Devices Inc, Barneveld, WI, USA); RESPeRATE; Heat/cold provocation

    Device: RESPeRATE (Paced Breathing) · Device: Quantum Warp10 (Red LED) · Other: Heat/cold provocation

  • Active comparator
    Near Infrared LED

    Light emitting diodes, 830 nm, 55 mW/cm2, Omnilux new-U (Photomedex, Horsham, PA, USA); RESPeRATE; Heat/cold provocation

    Device: RESPeRATE (Paced Breathing) · Device: Omnilux new-U (Near Infrared LED) · Other: Heat/cold provocation

Interventions

  • DeviceRESPeRATE (Paced Breathing)

    The subjects will be guided by a digital metronome to breath at 15, 10, and 6 breaths/min for 2 minutes each using the metronome function of the device RESPeRATE (InterCure, Israel) that guides breathing using musical tones played at selectable rhythm.

  • DeviceQuantum Warp10 (Red LED)
  • DeviceOmnilux new-U (Near Infrared LED)
  • OtherHeat/cold provocation

    Immersion of one foot in a warm water bath ( 43-45 degrees C) for few seconds and then immersion of the same foot in cold water bath (5-7 degrees C) for 1 min.

06

What researchers measure

Primary outcomes

  1. MRT as measured from finger Photoplethysmography in response to changes in breathing rate

    Time frame: Change from baseline to up to 1 minute after termination of 2 minutes of constant breathing rate (15, 10, and 6 breath/min)

  2. MRT as measured from finger Photoplethysmography in response to light source

    Time frame: Change from immediately before exposure to light source to up to 10 minutes after exposure to light source

  3. MRT as measured from finger Photoplethysmography in response to temperature changes

    Time frame: Change from immediately before exposure to temperature provocations to up to 2 minutes after exposure to warm water, and up to 2 minutes after exposure to cold water

Secondary outcomes

  1. Capillary blood flow (red blood cell velocity or flux in 'perfusion units') as measured by laser doppler

    Time frame: At baseline, 1 minute after each changes in breathing rate, 5 and 10 minutes after exposure to light source, 1 minutes after each exposure to temperature changes

  2. Transcutaneous oxygen pressure (tcpO2 in mmHg)

    Time frame: At baseline, 1 minute after each changes in breathing rate, 5 and 10 minutes after exposure to light source, 1 minutes after each exposure to temperature changes

07

Study locations

1 site
  • Afeka, Tel-Aviv Academic College of Engineering
    Tel Aviv, Israel
08

References and documents

Publications

  • Gavish B. Plethysmographic characterization of vascular wall by a new parameter--minimum rise-time: age dependence in health. Microcirc Endothelium Lymphatics. 1986-1987;3(3-4):281-96. PubMed 3431526 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02527070
Lead sponsor
Afeka, The Tel-Aviv Academic College of Engineering
Responsible party
Sponsor
First posted
Aug 18, 2015
Start date
Sep 2015
Primary completion
Jun 2016
Completion
Oct 2016
Last update
Oct 17, 2016

Study contacts

Moshe Halak, MD
principal investigator · Sheba Medical Center
Zehava Blechman, PhD
study director · Afeka, Tel-Aviv Academic College of Engineering

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion